Myriad Genetics | MYGN - Loan Capital



Myriad Genetics reported $59.3M in Loan Capital for its fiscal quarter ending in March of 2025.


Loan Capital Change Date
Agilent USD 3.35B 1000K Jul/2025
Becton, Dickinson and Co. USD 17.53B 135M Jun/2025
Bio-Rad Laboratories USD 1.2B 400K Jun/2025
Bruker USD 2.38B 303.5M Jun/2025
Danaher USD 16.85B 877M Jun/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Illumina USD 1.49B 1000K Jun/2025
J&J USD 38.36B 7.7B Mar/2025
Mettler Toledo International USD 2.12B 232.49M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 5.17B 689M Jun/2025
Quidel USD 2.07B 33.8M Jun/2025
Repligen USD 533.72M 4.12M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Standard Biotools USD 299K 0 Jun/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Veracyte USD 0 0 Mar/2025
Waters USD 1.2B 159.76M Jun/2025